These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15510211)

  • 1. Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib.
    Piazza RG; Magistroni V; Gasser M; Andreoni F; Galietta A; Scapozza L; Gambacorti-Passerini C
    Leukemia; 2005 Jan; 19(1):132-4. PubMed ID: 15510211
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib.
    Gruber FX; Hjorth-Hansen H; Mikkola I; Stenke L; Johansen T
    Leukemia; 2006 Nov; 20(11):2057-60. PubMed ID: 17008892
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.
    Hochhaus A; Kreil S; Corbin AS; La Rosée P; Müller MC; Lahaye T; Hanfstein B; Schoch C; Cross NC; Berger U; Gschaidmeier H; Druker BJ; Hehlmann R
    Leukemia; 2002 Nov; 16(11):2190-6. PubMed ID: 12399961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not all imatinib resistance in CML are BCR-ABL kinase domain mutations.
    Wei Y; Hardling M; Olsson B; Hezaveh R; Ricksten A; Stockelberg D; Wadenvik H
    Ann Hematol; 2006 Dec; 85(12):841-7. PubMed ID: 17006667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib in chronic myelogenous leukemia.
    Chu SC; Tang JL; Li CC
    N Engl J Med; 2006 Sep; 355(10):1062-3; author reply 1063-4. PubMed ID: 16960978
    [No Abstract]   [Full Text] [Related]  

  • 6. The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib.
    Khorashad JS; Anand M; Marin D; Saunders S; Al-Jabary T; Iqbal A; Margerison S; Melo JV; Goldman JM; Apperley JF; Kaeda J
    Leukemia; 2006 Apr; 20(4):658-63. PubMed ID: 16467863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML.
    Popovici C; Charbonnier A; Gisserot O; Aguilon P; Rémy V; Olschwang S; Mozziconacci MJ
    Leuk Res; 2008 Feb; 32(2):361-2. PubMed ID: 17412419
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.
    Sherbenou DW; Wong MJ; Humayun A; McGreevey LS; Harrell P; Yang R; Mauro M; Heinrich MC; Press RD; Druker BJ; Deininger MW
    Leukemia; 2007 Mar; 21(3):489-93. PubMed ID: 17252009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib.
    Bennour A; Beaufils N; Sennana H; Meddeb B; Saad A; Gabert J
    J Clin Pathol; 2010 Aug; 63(8):737-40. PubMed ID: 20702476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients.
    Leguay T; Desplat V; Marit G; Mahon FX
    Leukemia; 2005 Dec; 19(12):2332-3; author reply 2333-4. PubMed ID: 16281074
    [No Abstract]   [Full Text] [Related]  

  • 11. Roots of clinical resistance to STI-571 cancer therapy.
    Barthe C; Cony-Makhoul P; Melo JV; Mahon JR
    Science; 2001 Sep; 293(5538):2163. PubMed ID: 11567109
    [No Abstract]   [Full Text] [Related]  

  • 12. Roots of clinical resistance to STI-571 cancer therapy.
    Hochhaus A; Kreil S; Corbin A; La Rosée P; Lahaye T; Berger U; Cross NC; Linkesch W; Druker BJ; Hehlmann R; Gambacorti- Passerini C; Corneo G; D'Incalci M
    Science; 2001 Sep; 293(5538):2163. PubMed ID: 11569495
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene.
    Janssen JJ; Hochhaus A; van Oostveen JW; Waisfisz Q; Schuurhuis GJ; Ossenkoppele GJ
    Leukemia; 2004 May; 18(5):1020-1. PubMed ID: 15014529
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
    Chien JH; Tang JL; Chen RL; Li CC; Lee CP
    Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.
    Scappini B; Gatto S; Onida F; Ricci C; Divoky V; Wierda WG; Andreeff M; Dong L; Hayes K; Verstovsek S; Kantarjian HM; Beran M
    Cancer; 2004 Apr; 100(7):1459-71. PubMed ID: 15042680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism and overcome against drug resistance to imatinib for treatment of chronic myeloid leukemia].
    Tauchi T; Oyashiki K
    Gan To Kagaku Ryoho; 2011 May; 38(5):749-53. PubMed ID: 21702118
    [No Abstract]   [Full Text] [Related]  

  • 17. BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay.
    Ono T; Miyawaki S; Kimura F; Kanamori H; Ohtake S; Kitamura K; Fujita H; Sugiura I; Usuki K; Emi N; Tamaki S; Aoyama Y; Kaya H; Naoe T; Tadokoro K; Yamaguchi T; Ohno R; Ohnishi K;
    Leuk Res; 2011 May; 35(5):598-603. PubMed ID: 21239056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [STI571: the resistance organizes!].
    Jeanteur P
    Bull Cancer; 2001 Sep; 88(9):819. PubMed ID: 11642306
    [No Abstract]   [Full Text] [Related]  

  • 19. BCR-ABL(T315I) transcript disappearance in an imatinib-resistant CML patient treated with homoharringtonine: a new therapeutic challenge?
    Legros L; Hayette S; Nicolini FE; Raynaud S; Chabane K; Magaud JP; Cassuto JP; Michallet M
    Leukemia; 2007 Oct; 21(10):2204-6. PubMed ID: 17541396
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytogenetic and molecular mechanisms of resistance to imatinib.
    Hochhaus A
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):69-79. PubMed ID: 12783379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.